Mediterranean Diet Push
New reviews this week reinforce Mediterranean staples for brain and heart health — researchers are highlighting probiotics plus olives, beans, lentils and fish for cognitive resilience. A new cookbook, 'A Culinary Journey: Heart‑Healthy Recipes…,' was published April 1, and dietitians recommend canned staples (olives, calamari, tuna, black beans, lentils) to make the diet travel‑ and schedule‑friendly. (irishdentist.ie) (globenewswire.com) (eatingwell.com)
A Frontiers systematic review that pooled 20 studies found the Mediterranean Diet consistently reshaped gut microbiota composition in patterns the authors linked to memory and other cognitive outcomes. (frontiersin.org) A separate systematic review of randomized, placebo‑controlled probiotic trials screened 2,307 articles and included 26 articles (19 studies, 762 participants), reporting imaging and electrophysiology changes after oral probiotic interventions. (nature.com) A 2025 meta‑analysis of randomized trials reported that probiotic supplementation produced small but measurable improvements on standardized cognitive tests across different age groups. (nature.com) An imaging study of 1,647 middle‑aged and older adults linked higher adherence to the MIND diet (a Mediterranean‑DASH hybrid) with structural findings consistent with roughly two years slower brain aging. (sciencealert.com) The GlobeNewswire/Palmetto press release for the newly issued cookbook names Marc J. Aguilera, Ed.D., as author and describes a “green heart” symbol used in the book to mark recipes that follow heart‑healthy Mediterranean principles. (financialcontent.com) EatingWell’s piece on Mediterranean‑friendly canned foods was widely syndicated (including MSN and lifestyle sites), and the coverage emphasized shelf‑stable protein and fiber sources as convenient, nutrient‑dense options for busy schedules. (diningandcooking.com) A registered clinical trial (NCT05029765) is currently evaluating a combined Mediterranean‑diet and probiotic intervention in adults with mild cognitive impairment, with planned endpoints including short‑chain fatty acids, neuropeptides and markers of oxidative stress and inflammation. (clinicaltrials.gov)
